0001209191-20-020912.txt : 20200324 0001209191-20-020912.hdr.sgml : 20200324 20200324161033 ACCESSION NUMBER: 0001209191-20-020912 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200315 FILED AS OF DATE: 20200324 DATE AS OF CHANGE: 20200324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moran Kevin Patrick CENTRAL INDEX KEY: 0001806596 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34186 FILM NUMBER: 20738485 MAIL ADDRESS: STREET 1: C/O VANDA PHARMACEUTICALS INC. STREET 2: 2200 PENNSYLVANIA AVENUE, SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001347178 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030491827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 202-734-3400 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-03-15 0 0001347178 Vanda Pharmaceuticals Inc. VNDA 0001806596 Moran Kevin Patrick C/O VANDA PHARMACEUTICALS INC. 2200 PENNSYLVANIA AVENUE, SUITE 300E WASHINGTON DC 20037 0 1 0 0 VP, Acting CFO & Treasurer Common Stock 14237 D Common Stock 2532 D Common Stock 12578 D Common Stock 18750 D Common Stock 12656 D Common Stock 635 I By Wife Stock Option (Right to Buy) 7.94 2026-02-11 Common Stock 6750 D Stock Option (Right to Buy) 12.27 2024-12-03 Common Stock 15000 D Stock Option (Right to Buy) 11.59 2023-12-02 Common Stock 15000 D Stock Option (Right to Buy) 3.12 2022-12-07 Common Stock 7500 D Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest in full on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through such vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest. Represents shares of common stock underlying an RSU award. One-half of the RSU will vest on February 28, 2021, and the remaining one-half of the RSU will vest on February 28, 2022, provided the Reporting Person remains continuously employed by the Issuer through each vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest. Represents shares of common stock underlying an RSU award. The RSU vests in three (3) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest. Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest. The option is fully vested and immediately exercisable. /s/ Kevin Patrick Moran 2020-03-24